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A B S T R A C T Lymph node (LNL) and salivary gland lymphocytes (SGL) from three patiernts with pseudolymphoma and primary Sj6gren's syndrome (loSS) were characterized with monoclonal antibodies to demonstrate (a) a predominance of T cells (>80%) reactive with anti-T cell antibodies OKT4 (>70%) and OKT8 (<20%); (b) a high prevalence of activation antigens (>50% of cells reactive with antibody OKT10 and antiIa antibody); (c) polyclonal B cells (8-15% of all cells expressing kappa or lambda); and (d) a specific B cell subset defined by reactivity with antibody B532 that was not present in their peripheral blood. In vitro functional studies showed that both SGL and LNL provided T helper activity for immunoglobulin synthesis and that this activity could be abolished by treatment with antibody OKT4 plus complement. The SGL and LNL exhibited little natural killer, antibody-dependent cellular cytotoxicity, or cytotoxic T cell activity. Normal karyotype was observed in SGL, LNL, and peripheral blood lymphocytes (PBL) from these patients. These findings indicate that pseudolymphoma in 1"SS results from the infiltration of salivary glands and extraglandular tissues by nonneoplastic T helper cells. Mono- clonal antibodies provide an important tool to distinguish pseudolymphoma from non-Hodgkins (B cell) lymphomas that have a markedly elevated incidence in 1SS patients. Our finding of T helper cells in pseudolymphoma tissues supports the hypothesis that chronic stimulation of 1 cells by helper T cells leads to eventual escape of a malignant B cell clone. INTRODUCTION Epidemiologic evidence suggests that the frequency of non-Hodgkin's lymphoma is increased in patients with autoimmune disease as a result of chronic antigenic stimulation and lymphoproliferation (reviewed by Ber- ard et al. [1] ). A particularly high prevalence of nonHodgkin's lymphoma has been noted in patients with Sjogren's syndrome (SS)1 (1-3), a disease characterized by lymphocytic infiltration of salivary and lacrimal glands (4) leading to symptomatic dry eyes and mouth. Although the majority of SS patients have benign infiltrates with minimal glandular enlargement, a small number develop massive swelling of salivary glands (5, 6) and cervical lymphadenopathy (3) (4) (5) clinically suggestive of lymphoma. However, biopsy samples from these patients do not meet histologic criteria for frank malignancy and these infiltrates have been termed pseudolymphomas (3) (4) (5) (6) ; these patients appear to be at particularly high risk for subsequent development of malignant lymphoma (1) (2) (3) (4) (5) (6) . The distinction between pseudolymphoma and lymphoma using routine histologic stains is often extremely difficult (2, 3) . We have found that monoclonal antibodies aid in differentiating these tissue lesions.
The etiopathogenesis of SS remains unknown but the presence of polyclonal hypergammaglobulinemia, au-toantibodies such as rheumatoid factor or antinuclear antibodies (ANA), and the association of SS with other autoimmune diseases such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), or scleroderma (2-6) suggest an autoimmune process. The cells infiltrating the minor salivary glands of primary Sj6gren's syndrome (loSS) patients are predominantly T cells (7) (8) (9) , while the non-Hodgkin's lymphomas that develop in these patients are predominantly B cells (9) (10) (11) (12) (13) (14) (15) . Therefore, the study of tissue from patients with pseudolymphoma is particularly important since it allows characterization of function and karyotype of lymphocytes in an autoimmune disease that appears to represent a transitional stage in the progression from benign lymphocytic infiltrates to lymphoma (2-5).
METHODS

Patients
All patients with loSS were seen at Scripps Clinic and Research Foundation (SCRF) and fulfilled the following criteria: grade IV lip biopsy on a scale of I-IV by the ChisholmMason Scale (16) ; a Schirmer's test of <5 mm of wetting in each eye after 5 min; typical filamentary keratitis after roseBengal staining; and absence of criteria sufficient for a diagnosis of RA, SLE, or scleroderma (4) . None of these patients had received corticosteroids or other immunosuppressive agents for at least 3 mo before evaluation of their lymphocyte subsets.
Salivary glands were surgically removed in three patients with 1°SS because of recurrent salivary gland infection. In each of these cases, the diagnosis of malignant lymphoma was considered unlikely based on their clinical features. The extent of lymphocytic infiltration was much less marked than in the pseudolymphoma cases. Only 25-50% of the lobules were infiltrated with lymphocytes in contrast to the pseudolymphoma patients where all lobules were extensively involved. Histologically normal lymph nodes and parotid tissues were obtained from three patients without neoplastic or autoimmune diseases for comparison.
Case reports of pseudolymphoma patients
The term "pseudolymphoma" in SS patients refers to extensive lymphocytic infiltration with disruption of normal architecture in glandular tissues and/or extraglandular sites such as cervical lymph nodes or lung (3) (4) (5) . The enlarged salivary glands and lymph nodes or pulmonary infiltrates fluctuate over the course of years and are not characterized by the progressive course expected of malignant lymphoma (3) (4) (5) (6) . Three cases that were clinically felt to represent pseudolymphoma and SS were seen at SCRF in the past 5 yr from a patient population of >70 patients with 1°SS: Case 1. This 54-yr-old white woman was first seen at SCRF in 1975 with massive bilateral parotid gland swelling (Fig. 1 (3 X 3 cm) , and bilaterally enlarged cervical lymph nodes. Biopsies of a left anterior cervical lymph node, left submandibular gland, and right parotid gland were obtained to exclude malignancy, and the lymphocytes from these tissues were characterized as described below.
Case 3. This 72-yr-old female, had increasingly dry eyes and dry mouth for 6 yr. 1 yr before admission, she developed tender and swollen parotid and submandibular glands bilaterally. Subsequently, a 2 X 2-cm right anterior cervical lymph node was noted and biopsied. At this time she had WBC 6.6 (40% lymphocytes), hemoglobin 13.3 g%, and quantitative immunoglobulin levels IgG 478 mg%, IgM 52 mg%, and IgM 57 mg%. Tests for rheumatoid factor and ANA were negative. 6 mo later she developed pain and swelling of the left eye that was found to result from a 2 X 2-cm mass within the orbit arising from the lacrimal gland. The lymph node and lacrimal gland mass were excised and examined with monoclonal antibodies.
Monoclonal antibodies
We utilized antibodies to lymphocyte cell surface antigens of the OKT series (OKT3, OKT4, OKT6, OKT1O, OKTII, OKM1) provided by Ortho Immunobiologic Research Division, Raritan, NJ, and the Leu series (Leu 2a, Leu 3a, Leu 4, and Leu 7) provided by the Becton, Dickinson & Co., Research Division, Mt. View, CA. The preparation and properties of these antibodies have been described previously (18) (19) (20) ; briefly, total T cells are detected by Leu 1 and Leu 4, while T helper cells are included in the Leu 3a+ subset, T suppressor cells in the Leu 2a+ subset, and natural killer (NK) cells in the Leu 7a+ subset in normal blood. However, when lymphocytes have been activated in vitro by mitogens, T cells of the Leu 3a subset can perform suppression, NK, or cytotoxic functions (21, 22) .
In staining cell suspensions for cytofluorographic analysis, the OKT and Leu reagents gave similar results (OKT3 = Leu 4; OKT4 = Leu 3a; OKT8 = Leu 2a); however, the Leu series of antibodies gave better staining of frozen tissue sections (23) and were used for this purpose. Antibody 3A1 reacts with normal T cells in thymus and blood (24) . Antibody SC1 (25) detects the same 67,000-D antigen on mature T cells as antibody OKTI or Leu 1 (18, 19) , and antibody SC2 reacts with an Ia-like molecule (23) . Antidelta, -kappa, -lambda, -gamma, and -mu antibodies were purchased from BRL Laboratories, Bethesda, MD. Antibody B532 reacts with a 45,000-D antigen present on B cells from germinal centers of normal lymph nodes but not on circulating PBL (9, 26) . Antibody L22 reacts with the transferrin receptor since it immunoprecipitates the same 90,000-D molecule2 detected by monoclonal antibody B3/25 that binds to this receptor (27) . Previous studies have demonstrated that expression of Ia-like antigen, OKT1O or transferrin receptor is not limited to a particular lineage since they may be found on T cells, B cells and/or monocytes in certain circumstances (18, 23, 27, 18) . A low percentage of T cells in normal peripheral blood or thymus express these antigens; however, mitogen stimulation in vitro leads to expression of these markers on the majority of T cell blasts and thus they can be termed activation antigens (27, 28 (8, 9) . The cells were then analyzed cytofluorometrically using a FACS IV fluorescenceactivated cell sorter (Becton, Dickinson & Co.) (29) . Peripheral blood lymphocytes (PBL) from the pseudolymphoma patients, 14 1°SS patients without pseudolymphoma, and 10 age-, sex-matched controls were prepared by Ficoll-Hypaque centrifugation after monocyte depletion by carbonyl iron and a magnet (30) and stained in a similar manner as the SGL. T cells were prepared from PBL by rosetting with neuraminidase-treated sheep erythrocytes (30) .
To remove particular subsets by complement-mediated lysis, 107 cells were incubated with monoclonal antibody OKT4, OKT8, or control myeloma protein in 1 ml phosphatebuffered saline, containing a 1:100 dilution of ascitic fluid for 0.5 h at 5°C, then washed, and 200 Ml of rabbit complement was added for 0.5 h at SoC followed by 0.5 h at 37°C. Complement-mediated lysis was determined to be >94% complete based on subsequent staining with FL-F(ab')2 antimouse immunoglobulin (Ig) and cytofluorographic analysis to detect cells stained but not lysed. Less Lymphocyte Subsets in Siogren's Syndrome 55 supernatants examined for total IgG and IgM and for rheumatoid factor (IgM anti-IgG) using a solid-phase enzymelinked immunosorbent assay (ELISA). A separate aliquot was analyzed using monoclonal antibodies to ascertain the proportion of T cells, B cells, and monocytes in the cultures on day 0. In certain experiments, non-T cells (0.5 X 106/ml) were mixed with T cells (0.5 X 106/ml) and incubated in round-bottom tubes as described above.
To determine the kinetics of antibody production, SGL or LNL (1.5 X 106 cells/ml) were placed in flat-bottom microtiter plates (3040 Microtest II, Falcon Labware) in RPMI 1640 containing 10% FCS. Polyclonal antibody production, was stimulated by addition of Fc fragments of a human IgGl myeloma protein (final concentration 0.1 or 1 sg/ml) and the number of plaque-forming cells (PFC) was determined 2, 4, and 6 d later (32) .
NK activity was determined using 51Cr-labeled K562 target cells and antibody-dependent cellular cytotoxicity (ADCC) using 51Cr-labeled Chang liver cells coated with rabbit antiChang cell antibody (33) . Cytotoxic T cell (CTL) activity was measured by the lysis of 5"Cr-labeled Epstein-Barr virus (EBV)-transformed B cells (34) . Lymphoblastoid cell lines from I1SS patients and from normal donors were established by infecting PBL with EBV (strain B95-8) and maintaining the cell lines in RPMI 1640 with 10% FCS (34) .
RESULTS
Lymphocyte infiltrates in SS patients with pseudolymphoma. The parotid and submandibular glands obtained from these patients showed almost complete replacement of the salivary gland tissue by a diffuse infiltration of lymphocytes (Fig. 2, frames A and B) . The architecture of the cervical lymph node (frame C), lung nodule (frame D), and minor salivary gland (frame E) also was distorted by lymphocytic infiltrates. In each of these tissues, small, normal-appearing lymphocytes and a subpopulation of large lymphoid cells with immunoblastic or plasmacytoid appearance (arrows in frame B) were present. There was preservation of the salivary gland lobular architecture and no infiltration *\., ' Monoclonal antibody staining of the salivary gland biopsy from each patient showed that the majority of lymphocytes were T cells (reactive with antibody Leu 4), although some B cells (reactive with antidelta antibody) were also present (Fig. 3, frames A and B) . Similar results were obtained when total T cells were detected with antibodies SCI (25) (9) , was found to react with scattered cells (frame C). Detection of cell surface Ig (i.e., B cells) using antikappa or antilambda antibodies was difficult due to the large amount of interstitial Ig present. Plasma cells, detected by their cytoplasmic Ig were relatively rare (<10%) in these tissues. Analysis of lymph node biopsies from each patient and the lacrimal gland mass in patient 3 gave similar results.
Cytofluorographic analysis of lymphocyte subsets in salivary gland and peripheral blood. Cytofluorographic analysis of SGL was performed to confirm the results of staining frozen sections and to obtain a more precise quantitation of the percent stained cells. As shown in Table I antibody SC2 that detects on Ia-like antigen in frame A; antibody OKT1O in frame B; antibody B532 in frame C; myeloma protein MOPC-21 that contains no anti-cell activity and thus serves as a control for nonspecific binding in frame D. Table I . Similarly, the lacrimal gland mass in patient 3 had a similar phenotype to her SGL. Thus, we found similarity in each of the tissue biopsies analyzed from the pseudolymphoma patients. Finally, we have compared the phenotype of SGL in pseudolymphoma patients to SGL obtained from patients without pseudolymphoma (three cases) and to LNL from tonsils of otherwise normal adults. As shown in Table II , the phenotypes of lymphocytes from these sources were similar; a slightly lower percentage of cells reactive with activation antigens was noted in the LNL.
In vitro functional analysis of lymphocyte subsets for T helper activity. SGL from these patients can synthesize Ig in vitro (Fig. 5) . This activity was abolished by treatment of SGL from patient 2 or 3 or of normal LNL by antibody OKT4 plus complement (Fig.   5 ). However, SGL from patients synthesized Ig even after this treatment, suggesting that the B cells had been previously stimulated in vivo. To determine whether these T cells possessed helper activity, we separated her SGL into T and non-T cell subpopulations. The T cells possessed helper activity based on their ability to stimulate normal B cells to secrete Ig (Fig.  6 ). Her non-T cells spontaneously (i.e., in the absence of PWM) secreted Ig (data not shown), thus confirming our observation that OKT4 and complement did not abolish Ig production. Taken together, these results demonstrate that salivary gland T cells of each patient possess helper activity. Kinetic Table III ). This result is consistent with the diminished number of cells staining with antibody Leu 7 (Table I) , which detects the subset containing NK and ADCC cells in normal blood (20) .
OKT4+ T cells derived from normal controls also may possess CTL function (22) , apparently directed against target cells bearing Ia-like antigens (36, 37 (39) . The high frequency of autoimmune disease in 1°SS patients, including thyroiditis, supports the hypothesis that similar pathogenetic mechanisms are operative in each disease.
The prevalence of non-Hodgkins lymphoma is increased in patients with SS (1-3). These lymphomas are most commonly classified as histiocytic lymphoma or reticulum cell sarcoma (2-4), although other histologic types including myeloma, Waldenstrom's macroglobulinemia, and Franklin's heavy chain disease have been observed (11) (12) (13) (14) . Immunologic markers have indicated that lymphomas in SS patients are of B cell origin (1, (11) (12) (13) (14) (15) 40) . Actual progression from pseudolymphoma to frank malignancy was observed in one of our patients (case 1) and has been reported previously (5-7, 10, 13) . In our patients with pseudolymphoma, the majority of cells were polyclonal T cells (both OKT4+ and OKT8+ subsets present) although OKT4+ cells predominated. These T cells differed from those present in Sezary syndrome, a T helper lymphoma, in their ability to react with antibody 3A1 (24) . Based on these findings, the patient's age of onset of disease and their long clinical course, it is unlikely that these patients had occult T cell lymphoma. In addition, the pseudolymphoma cells had normal karyotype, in contrast to the chromosomal translocation noted in the majority of patients with malignant lymphoma (41) .
Since distinction between pseudolymphoma and frank lymphoma is often difficult using routine histologic stains (2) (3) (4) , monoclonal antibodies provide a tool to aid in distinguishing these conditions.
Functional studies revealed that pseudolymphoma T cells provided helper function for antibody production. Relatively little NK or ADCC activity was noted in the SGL even though these activities may be found in OKT4+ T-cells from normal donors after in vitro activation by mitogens (21, 22) . Similar to normal PBL or LNL, the SGL did not exhibit CTL activity against autologous EBV-transformed B cells. However, the SGL could be activated in vitro to lyse these target cells. Since the induction of CTL activity requires T inducer cells (34, 38) , we conclude that SGL must contain this activity.
Our findings suggest the following sequence of events in the pathogenesis of SS. Initially, OKT4+ T cells home to salivary gland tissue as a result from tissue-specific localization of antigen (42) and/or specific accessory cells (43) . This is followed by clonal expan-sion of these T cells with concomitant expression of activation antigens (OKT1O, Ia, L22) associated with cell replication (23, 28) . As the foci of T lymphocytes become larger, B cells bearing the B532 antigen (found on normal germinal center B cells but not on circulating B cells) are detected (9) and synthesize Ig and autoantibodies (44) . In certain patients, proliferation of OKT4+ T cell occurs leading to glandular enlargement. This is the pseudolymphoma stage. Under the influence of chronic T helper cell stimulation, B cells may eventually undergo certain changes, e.g., a chromosomal translocation that confers a selective growth advantage, leading to non-Hodgkin's lymphoma (41, 45) . The development of the lymphoma in SS may depend on environmental factors such as radiation or cytotoxic agents that decrease the T cell regulatory controls or increase the chance of chromosomal alterations (1) (2) (3) 45) . This hypothesis is supported in part by a recent study of patients with non-Hodgkin's lymphoma (but without reported SS) demonstrating increased T helper activity in their peripheral blood (46) . Therefore, patients with pseudolymphoma in SS may occupy an intermediate position in the spectrum ranging from "benign" T cell salivary gland infiltrates to the B cell neoplasms of non-Hodgkin's lymphoma.
